1. Adamo MDL, Ruhl J (2015) National Cancer Institute SEER Coding and Staging Manual 2015. . National Cancer Institute: Bethesda, MD, USA, pp 20850–29765.
2. Aguilo R, Macia F, Porta M, Casamitjana M, Minguella J, Novoa AM (2008) Multiple independent primary cancers do not adversely affect survival of the lung cancer patient. Eur J Cardiothoracic Surg 34 (5): 1075–1080.
3. Ahn DH, Mehta N, Yorio JT, Xie Y, Yan J, Gerber DE (2013) Influence of medical comorbidities on the presentation and outcomes of Stage I-III non-small-cell lung cancer. Clin Lung Cancer 14: 644–650.
4. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, BKe Edwards (eds) (2010) SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/ . Based on November 2009 SEER data submission, posted to the SEER web site.
5. Bunn PA Jr, Lilenbaum R (2003) Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 95 (5): 341–343.